Skip to Content
Merck

LC/MS Analysis of Clenbuterol Enantiomers in Plasma on Astec® CHIROBIOTIC® T after SPE using HybridSPE®-Phospholipid

LC/MS Analysis of Clenbuterol Enantiomers in Plasma on Astec® CHIROBIOTIC® T after SPE using HybridSPE®-Phospholipid application for HPLC

Materials

analytical column

Product No.
Description
Pricing

Astec® CHIROBIOTIC® T Chiral HPLC Column

5 μm particle size, L × I.D. 10 cm × 2.1 mm

Application

Product No.
Description
Pricing

LC/MS Analysis of Clenbuterol In Plasma on Astec® CHIROBIOTIC® T with Phospholipid Removal using HybridSPE® Phospholipid

application for SPE, application for LC-MS

HPLC Analysis of Clenbuterol Enantiomers on Astec® CHIROBIOTIC® T

application for HPLC

HPLC Analysis of Clenbuterol Enantiomers on Astec® CHIROBIOTIC® T2

application for HPLC

SPE tube or plate

Product No.
Description
Pricing

HybridSPE®-Phospholipid

96-well Plate, bed wt. 50 mg, volume 2 mL, pk of 1

HybridSPE®-Phospholipid

Cartridge, bed wt. 30 mg, volume 1 mL, pk of 100

standard

Product No.
Description
Pricing

Clenbuterol hydrochloride

≥95%

CONDITIONS

column

CHIROBIOTIC T, 10 cm x 2.1 mm I.D., 5 μm particles (12018AST)

mobile phase

10 mM ammonium formate in methanol

flow rate

0.3 mL/min

column temp.

30 °C

detector

ESI(+)

sample

clenbuterol, 10 ng/mL in rat plasma (phospholipids removed by extraction with HybridSPE-Phospholipid)

Description

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany